Collagen Market Size to Grow by USD 2,866.14 million from 2022 to 2027: Growing demand for collagen from the healthcare industry to boost the growth

NEW YORK, June 12, 2023 /PRNewswire/ — The collagen market size is estimated to increase by USD 2,866.14 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 7.75%. The rising demand for collagen from the healthcare industry is one of the major drivers of the global collagen market. Collagen … Read more

Medical waste disposal market size is to grow by USD 3,323.84 million from 2022 to 2027; The growing healthcare industry will boost the market

NEW YORK, June 12, 2023 /PRNewswire/ — The medical waste disposal market is set to grow by USD 3,323.84 million from 2022 to 2027. However, the growth momentum will progress at a CAGR of 5.5% during the forecast period, according to Technavio. The medical waste disposal market is fragmented, and the vendors are seeking strong partnerships with … Read more

towards a finally effective repellent?

Israeli researchers are developing a natural repellent that can reduce bites by 80%. At the end of last April, the magazine PNAS Nexus published an article outlining the results of a study conducted by researchers from the Hebrew University of Jerusalem, Israel. And it may well be that they have succeeded, even if tests must … Read more

Medical deserts: the regulation of the installation of doctors at the heart of the debates in the National Assembly

the essential The National Assembly will look, from this Monday, June 12, on a bill aimed at fighting against medical deserts. Among the measures mentioned, an amendment on the conditioning of the installation of doctors in areas already well provided with caregivers. How to fight against medical deserts? The question is back on the table … Read more

La FDA approuve CorNeat EverPatch, le premier substitut tissulaire synthétique non dégradable pour la chirurgie ophtalmique

CorNeat EverPatch est sur le point de remplacer l’utilisation de tissus de donneurs et de tissus traités, couramment utilisés dans les chirurgies oculaires, présentant  un risque de transmission de maladies. Le Dr Gilad Litvin, médecin en chef et co-fondateur de CorNeat Vision, a déclaré : « Le matériau de greffe idéal doit être durable, stérile, immunologiquement inactif, esthétiquement acceptable et facilement … Read more

FDA Clears CorNeat EverPatch, World’s First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery

The CorNeat EverPatch is poised to displace the use of donor and processed tissue, commonly utilized in ocular surgeries but posing the risk of disease transmission. Dr. Gilad Litvin, CorNeat Vision’s Chief Medical Officer and Co-Founder stated: “The ideal graft material should be long-lasting, sterile, immunologically inactive, cosmetically acceptable, and readily available. The CorNeat EverPatch … Read more

FDA genehmigt CorNeat EverPatch, das weltweit erste nicht degradierbare synthetische Gewebeersatzmaterial für die Augenchirurgie

Der CorNeat EverPatch ist in der Lage, die Verwendung von Spender- und verarbeitetem Gewebe zu ersetzen, das üblicherweise bei Augenoperationen eingesetzt wird, aber das Risiko von Krankheitsübertragungen birgt. Dr. Gilad Litvin, Chief Medical Officer und Mitbegründer von CorNeat Vision, erklärte: „Das ideale Transplantatmaterial sollte langlebig, steril, immunologisch inaktiv, kosmetisch akzeptabel und leicht verfügbar sein. Genau … Read more

Indivior to Commence Trading on Nasdaq

Company to Ring Opening Bell June 14 to Bring Awareness to Addiction Treatment; Company Will Maintain Premium Listing on London Stock Exchange RICHMOND, Va., June 12, 2023 /PRNewswire/ — Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses, … Read more